Cargando…
The role of animal models in advancing amyloid-beta immunotherapy to the clinic
The amyloid-beta (Aβ) hypothesis of Alzheimer's disease (AD) causality is now well into its third decade and is finally entering a phase of rigorous clinical testing in numerous late stage clinical trials. The use of Aβ-based animal models of AD has been essential to the discovery and/or precli...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949588/ https://www.ncbi.nlm.nih.gov/pubmed/20682084 http://dx.doi.org/10.1186/alzrt46 |